Stay updated with breaking news from Nasdaq Imcc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IM Cannabis (NASDAQ:IMCC – Get Rating) and ChromaDex (NASDAQ:CDXC – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, valuation, profitability, analyst recommendations, earnings and dividends. Earnings and Valuation This table compares IM Cannabis and ChromaDex’s […]
IM Cannabis Corp. (NASDAQ:IMCC – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 232,500 shares, an increase of 120.8% from the May 15th total of 105,300 shares. Based on an average daily trading volume, of 256,100 shares, […]
Zacks Investment Research lowered shares of IM Cannabis (NASDAQ:IMCC – Get Rating) from a hold rating to a sell rating in a research report report published on Thursday morning, Zacks.com reports. According to Zacks, “IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and […]
IM Cannabis (NASDAQ:IMCC – Get Rating) will be posting its quarterly earnings results after the market closes on Thursday, May 12th. Analysts expect IM Cannabis to post earnings of ($0.01) per share for the quarter. IM Cannabis has set its Q4 2021 guidance at EPS and its FY 2021 guidance at EPS. IM Cannabis (NASDAQ:IMCC […]
IM Cannabis Corp. (NASDAQ:IMCC – Get Rating) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 357,500 shares, a growth of 138.0% from the March 15th total of 150,200 shares. Approximately 0.7% of the shares of the stock are sold short. Based on an average daily […]